INDUSTRY-ACADEMIC COOPERATION FOUNDATION; YONSEI UNIVERSITY
发明人:
KIM, Hyun Seok,김현석,CHEONG, Jae Ho,정재호
申请号：
KRKR2017/007519
公开号：
WO2018/016797A1
申请日:
2017.07.13
申请国别(地区):
WO
年份:
2018
代理人:
摘要：
The present invention relates to a pharmaceutical composition for preventing or treating a resistant cancer, a recurrent cancer or a metastatic cancer and, more specifically, to a pharmaceutical composition for preventing or treating a resistant cancer, a recurrent cancer or a metastatic cancer by using a nicotinamide phosphoribosyltransferase (NAMPT) inhibitor. The present invention can be used for preventing and/or treating cancer by effectively inducing the growth and death of cells of a resistant cancer, a recurrent cancer or a metastatic cancer, in particular, among other cancers.Linvention porte sur un composé pharmaceutique destiné à prévenir ou à traiter un cancer résistant, récurrent ou métastatique à laide dun inhibiteur de nicotinamide phosphoribosyltransférase (NAMPT). Cette invention peut être utilisée pour prévenir et/ou traiter le cancer en provoquant la croissance et la mort des cellules dun cancer résistant, récurrent ou métastatique.본 발명은 내성암, 재발암, 또는 전이암의 예방 또는 치료용 약학 조성물, 보다 상세하게는 NamPT(Nicotinamide phosphoribosyltransferase) 저해제를 이용한 내성암, 재발암 또는 전이암의 예방 또는 치료용 약학 조성물에 관한 것으로, 암 중에서도 특히 내성암, 재발암, 또는 전이암 세포의 세포 증식 및 세포사멸을 효과적으로 유도하여 암을 예방 및/또는 치료하는데 사용될 수 있다.
